New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Lotus Ventures Inc.
J.CN
Shape
US Flag

CNQ

Unprofitable

EPS improving

Unprofitable

EPS improving

899698

Drug Manufacturers - Specialty & Generic

Next Earning date - 30 Oct 2024

899698

Drug Manufacturers - Specialty & Generic

Next Earning date - 30 Oct 2024

0.01CAD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

100%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

80%

Quote Panel

Shape
Updated October 25, 2024
1W % 1M % 3M % 1Y -60.00 %

Key Metrics

Shape
  • Market Cap

    899698


  • Shares Outstanding

    89.97M


  • Share in Float

    75.10M


  • Dividende

    0


  • Earning Date

    30 Oct 2024


  • Price Target

    0.01


  • Average Volume

    36651


  • Beta

    -0.317


  • Range

    0.0-0.05


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.lotuscannabis.ca


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.49x

P/S Ratio

0.10x

P/B Ratio

0.3

Debt/Equity

-63.2%

Net Margin

$-0.0

EPS

How J.CN compares to sector?

P/E Ratio

Relative Strength

Shape

J.CN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.21

arrow
arrow

N/A

0
vs NA

Q3.21

arrow
arrow

N/A

0
vs NA

Q4.21

arrow
arrow

+119%

0
vs -0.00

Q1.22

arrow
arrow

-46%

0
vs 0

Q2.22

arrow
arrow

N/A

-0.00
vs 0

Q3.22

arrow
arrow

N/A

-0.06
vs 0

Q4.22

arrow
arrow

N/A

-0.01
vs 0

Q1.23

arrow
arrow

N/A

-0.00
vs 0

Q2.23

arrow
arrow

N/A

-0.01
vs -0.00

Q3.23

arrow
arrow

N/A

NA
vs -0.06

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.21

arrow
arrow

-19%

1.4M  vs 1.8M

Q3.21

arrow
arrow

-31%

1.2M  vs 1.8M

Q4.21

arrow
arrow

-70%

410.6K  vs 1.4M

Q1.22

arrow
arrow

-74%

370.6K  vs 1.4M

Q2.22

arrow
arrow

-68%

459.1K  vs 1.4M

Q3.22

arrow
arrow

-64%

449.6K  vs 1.2M

Q4.22

arrow
arrow

-65%

144.6K  vs 410.6K

Q1.23

arrow
arrow

+59%

589.2K  vs 370.6K

Q2.23

arrow
arrow

+12%

512.7K  vs 459.1K

Q3.23

arrow
arrow

+67%

751.7K  vs 449.6K

Return on EquityShape

status-upQoQ

Q4.21

arrow
arrow

+0%

0
vs 0

Q1.22

arrow
arrow

+1%

0.01
vs 0

Q2.22

arrow
arrow

-1%

-0.01
vs 0.01

Q3.22

arrow
arrow

-46%

-0.46
vs -0.01

Q4.22

arrow
arrow

-8%

-0.08
vs -0.46

Q1.23

arrow
arrow

-2%

-0.02
vs -0.08

Q2.23

arrow
arrow

-3%

-0.03
vs -0.02

Q3.23

arrow
arrow

-7%

-0.07
vs -0.03

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News